journal article·2024-06-26Open access

DNA Anchoring Strength Directly Correlates with Spherical Nucleic Acid–Based HPV E7 Cancer Vaccine Potency

Jeongmin Hwang, Jasper Wilson Dittmar, Janice Kang, Tonatiuh Ocampo, Michael Evangelopoulos, Zhenyu Han, Sergej Kudruk, Jochen Lorch, Chad A. Mirkin

Nano Letters· Volume 24· Issue 25

Abstract

Vaccination for cancers arising from human papillomavirus (HPV) infection holds immense potential, yet clinical success has been elusive. Herein, we describe vaccination studies involving spherical nucleic acids (SNAs) incorporating a CpG adjuvant and a peptide antigen (E7 11–19 ) from the HPV-E7 oncoprotein. Administering the vaccine to humanized mice induced immunity-dependent on the oligonucleotide anchor chemistry (cholesterol vs (C12) 9 ). SNAs containing a (C12) 9 -anchor enhanced IFN-γ production >200-fold, doubled memory CD8 + T-cell formation, and delivered more than twice the amount of oligonucleotide to lymph nodes in vivo compared to a simple admixture. Importantly, the analogous construct with a weaker cholesterol anchor performed similar to admix. Moreover, (C12) 9 -SNAs activated 50% more dendritic cells and generated T-cells cytotoxic toward an HPV + cancer cell line, UM-SCC-104, with near 2-fold greater efficiency. These observations highlight the pivotal role of structural design, and specifically oligonucleotide anchoring strength (which correlates with overall construct stability), in developing efficacious therapeutic vaccines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · RNA Interference and Gene Delivery · vaccines and immunoinformatics approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States

Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States

Department of Interdisciplinary Biological Sciences, Northwestern University, 2 Sheridan Road, Evanston, Illinois 60208, United States

Department of Medicine, Hematology/Oncology Division, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, United States

Funding

National Cancer Institute · Northwestern University · Division of Materials Research · Alexander S. Onassis Public Benefit Foundation · Airforce Office of Scientific Research

References (44)

Show source-provided references
1. 10.1001/jamanetworkopen.2022.253010.1001/jamanetworkopen.2022.2530 ↗
2. 10.32481/djph.2023.04.00810.32481/djph.2023.04.008 ↗
3. 10.1016/j.tvr.2021.20021310.1016/j.tvr.2021.200213 ↗
4. 10.1038/s41591-020-01225-110.1038/s41591-020-01225-1 ↗
5. 10.1126/sciadv.adf370010.1126/sciadv.adf3700 ↗
6. 10.1074/jbc.M110.12672210.1074/jbc.M110.126722 ↗
7. ClinicalTrials.gov, Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer. https://clinicaltrials.gov/study/NCT02865135 (accessed 01/08/2024).
8. 10.1021/ja209351u10.1021/ja209351u ↗
9. 10.1016/j.mtbio.2023.10075010.1016/j.mtbio.2023.100750 ↗
10. 10.1021/acscentsci.2c0022710.1021/acscentsci.2c00227 ↗
11. 10.1126/scitranslmed.abb394510.1126/scitranslmed.abb3945 ↗
12. 10.3389/fimmu.2022.107377710.3389/fimmu.2022.1073777 ↗
13. 10.3389/fimmu.2020.0133310.3389/fimmu.2020.01333 ↗
14. 10.1038/s41551-022-01000-210.1038/s41551-022-01000-2 ↗
15. 10.1073/pnas.150285011210.1073/pnas.1502850112 ↗
16. 10.1073/pnas.190280511610.1073/pnas.1902805116 ↗
17. 10.1002/adhm.20210126210.1002/adhm.202101262 ↗
18. 10.1021/jacs.7b1257910.1021/jacs.7b12579 ↗
19. 10.1021/acscentsci.1c0077910.1021/acscentsci.1c00779 ↗
20. 10.1002/smll.20170290910.1002/smll.201702909 ↗
21. 10.1021/acscentsci.1c0018110.1021/acscentsci.1c00181 ↗
22. 10.1021/acsnano.3c0433310.1021/acsnano.3c04333 ↗
23. 10.4049/jimmunol.156.7.247310.4049/jimmunol.156.7.2473 ↗
24. 10.1021/acscentsci.3c0062510.1021/acscentsci.3c00625 ↗
25. 10.34133/bmef.003810.34133/bmef.0038 ↗
26. 10.1073/pnas.190280511610.1073/pnas.1902805116 ↗
27. 10.1038/s41551-022-01000-210.1038/s41551-022-01000-2 ↗
28. 10.1006/taap.1997.821810.1006/taap.1997.8218 ↗
29. 10.1080/2162402X.2019.164817010.1080/2162402X.2019.1648170 ↗
30. 10.1002/eji.20083813610.1002/eji.200838136 ↗
31. 10.1021/acsnano.9b0725410.1021/acsnano.9b07254 ↗
32. 10.1021/acsnano.6b0734310.1021/acsnano.6b07343 ↗
33. 10.1007/s12274-019-2301-310.1007/s12274-019-2301-3 ↗
34. 10.3389/fphar.2022.88740210.3389/fphar.2022.887402 ↗
35. 10.1021/acsnano.9b0725410.1021/acsnano.9b07254 ↗
36. 10.1016/S1471-4906(03)00111-X10.1016/S1471-4906(03)00111-X ↗
37. 10.1021/ja504845f10.1021/ja504845f ↗
38. 10.1073/pnas.130580411010.1073/pnas.1305804110 ↗
39. 10.1038/s41423-023-00990-610.1038/s41423-023-00990-6 ↗
40. 10.1073/pnas.200234511710.1073/pnas.2002345117 ↗
41. 10.3389/fimmu.2021.74919010.3389/fimmu.2021.749190 ↗
42. 10.1172/JCI13199210.1172/JCI131992 ↗
43. 10.1016/j.molimm.2023.05.00710.1016/j.molimm.2023.05.007 ↗
44. 10.1002/hed.2196210.1002/hed.21962 ↗